Clinical Trial Update: Predictive Value of Tumor Vascular Normalization Scoring in HER-2 Positive Breast Cancer

View source ↗

Summary

Clinical trial update on the predictive value of tumor vascular normalization scoring in HER2-positive breast cancer treated with neoadjuvant therapy. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Chongqing General Hospital | Conditions: HER2 Positive Breast Carcinoma, Neoadjuvant Therapy | Status: ACTIVE_NOT_RECRUITING